NCT07828171

Brief Summary

A randomized controlled trial that compares the antibacterial effectiveness of three mouthwashes-licorice, clove, and chlorhexidine-in Egyptian children aged 7-12 years. The main focus is Streptococcus mutans, one of the main bacteria associated with dental caries. The saliva samples will be collected from the children and the amount of S. mutans will be measured before and after using the assigned mouthwash. The children will be randomly divided into groups, with each group receiving one of the three mouthwashes. The bacterial counts will then be compared to determine which mouthwash is most effective at reducing salivary S. mutans. The research question is whether natural mouthwashes made from licorice or clove reduce the bacteria that cause cavities as effectively as chlorhexidine in children? The study could help determine whether licorice and clove are effective natural alternatives or adjuncts to chlorhexidine, particularly considering that chlorhexidine can have undesirable effects with prolonged use. Overall aim: Compare and evaluate the antibacterial efficacy of the three mouthwashes

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Oct 2025Jun 2027

Study Start

First participant enrolled

October 6, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 18, 2026

Status Verified

September 1, 2026

Enrollment Period

1.2 years

First QC Date

September 7, 2026

Last Update Submit

September 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Reduction of dental caries incidence in high-caries index pediatric patients using International Caries Detection and Assessment System.

    Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.

Secondary Outcomes (3)

  • The reduction in Streptococcus mutans count following the use of licorice and clove mouthwashes in Egyptian pediatric patients aged from 7 to 12.

    Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.

  • Patient reported satisfaction, regarding the taste using a questionnaire.

    Through study completion, an average of 3 months.

  • Adverse events related to the use of the licorice and clove mouthwashes, regarding oral irritation and allergies using a questionnaire.

    Through study completion, an average of 3 months.

Study Arms (3)

Chlorohexidine Mouthwash

ACTIVE COMPARATOR
Other: Mouth wash

Clove mouthwash

EXPERIMENTAL
Other: Mouth wash

Licorice mouthwash

EXPERIMENTAL
Other: Mouth wash

Interventions

The interventions will consist of three different mouthwashes: licorice mouthwash, clove mouthwash, and 0.2% chlorhexidine mouthwash. Each participant will use the mouthwash assigned to their study group according to the standardized study protocol. The herbal mouthwashes will be prepared using standardized licorice and clove extracts at predetermined concentrations, while the chlorhexidine group will receive 0.2% chlorhexidine mouthwash as the positive control. All mouthwashes will be provided in identical, appropriately labeled containers to maintain blinding where applicable. The interventions will be distinguished by their active ingredient and concentration, while the method, frequency, duration of use, and volume administered will be standardized across all groups.

Chlorohexidine MouthwashClove mouthwashLicorice mouthwash

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients with high caries index based on CAMBRA.
  • Frankl scale 3 and 4 (cooperative).

You may not qualify if:

  • Patients with teeth showing signs of infection (abscess or fistula)
  • Patients with mucositis (can't be given alcohol containing mouthwashes)
  • Hypertensive patients.
  • Allergic patients.
  • Special health care patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The British university in Egypt

Cairo, Cairo Governorate, Egypt

Location

MeSH Terms

Conditions

Dental CariesStreptococcal Infections

Interventions

Mouthwashes

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Intervention Hierarchy (Ancestors)

Biomedical and Dental MaterialsSpecialty Uses of ChemicalsChemical Actions and UsesCosmeticsManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary investigator

Study Record Dates

First Submitted

September 7, 2026

First Posted

September 18, 2026

Study Start

October 6, 2025

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

September 18, 2026

Record last verified: 2026-09

Locations